SBI Life Insurance Company quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	24,292	22,809	+6.5%
EBITDA	554	513	+7.9%
Profit before tax	554	513	+7.9%
Net profit	549	495	+11.0%
EPS	₹5.47	₹4.93	+11.0%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Earlier quartersAlpha Plus

Expenses
	24,292	46,091	5,658	45,803	22,809	38,696	24,169	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	23,939	45,551	3,464	45,376	22,609	38,228	22,606
	554	746	816	598	513	611	841
	554	746	816	598	513	611	841
Profit
	554	746	816	598	513	611	841
	36.1	47.3	51.2	44.4	18.6	45.2	60.0
	549	725	805	577	495	594	814
Per share
	₹5.47	₹7.22	₹8.02	₹5.75	₹4.93	₹5.93	₹8.11
Revenue detail — as filed
	356	282	326	356	322	293	251
	−2,614	25,977	−23,939	15,531	−2,055	21,525	−1,041
Expense detail — as filed
	35.3	54.3	95.7	56.6	42.1	43.8	76.0
	892	799	707	1,008	828	709	682
	1,370	930	859	1,610	1,240	666	998
	1,370	930	859	1,610	1,240	786	777
	164	−0.3	−21.1	−0.8	42.1	−12.4	6.5
	0.2	0.1	0.3	0.2	0.2	0.3	0.1
Profit build-up — alternate / pre-Ind-AS tags
	554	746	816	598	513	611	841
	4.5	20.9	11.1	20.8	18.6	16.6	27.1
	36.1	47.3	51.2	44.4	18.6	45.2	60.0
	4.5	20.9	11.1	20.8	18.6	16.6	27.1
	549	725	805	577	495	594	814
	549	725	805	577	495	594	814
	19,104	18,555	17,830	17,296	16,720	16,225	15,631
Per share — as-filed variants
	₹5.47	₹7.23	₹8.02	₹5.75	₹4.93	₹5.93	₹8.12
	₹5.47	₹7.22	₹8.02	₹5.75	₹4.93	₹5.93	₹8.11
Appropriations & transfers
	19,390	18,822	18,083	17,523	16,921	16,405	15,791
	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Insurance — revenue account (Policyholders')
	27,115	21,290	27,939	30,449	25,084	17,814	24,002
	26,878	20,078	27,684	30,245	24,848	17,178	23,861
	5,756	4,955	5,093	7,919	5,289	3,539	4,859
	15,764	12,382	16,714	17,472	14,003	10,546	14,680
	5,596	3,953	6,132	5,058	5,792	3,728	4,463
	875	612	416	1,086	795	394	567
	411	252	440	434	354	224	371
	84.2	65.7	2.6	90.6	90.8	48.7	59.9
	3,087	2,565	2,527	3,519	2,759	1,915	2,015
	1,717	1,635	1,668	1,909	1,519	1,129	1,238
	13.0	6.9	2.7	4.9	14.6	7.5	10.4
	15,514	13,127	16,255	14,468	13,482	10,118	12,528
	5,136	29,812	−15,348	27,347	6,039	25,900	7,706
	0.0	0.0	2,061	0.0	0.0	0.0	1,967
	3.1	6.8	8.4	6.3	8.7	6.4	18.2
	236	128	259	183	148	83.5	164
	0.5	0.4	−0.1	−3.4	268	261	290
	353	540	2,194	427	200	468	1,563
	353	540	2,194	427	200	468	1,563
	111	82.1	−170	158	−5.6	147	−384
	24.8	25.1	0.2	0.3	0.3	0.3	0.3
Insurance — Shareholders' account
	356	282	326	356	322	293	251
	598	740	2,690	626	528	614	2,199
	44.0	−6.3	1,874	28.0	14.9	3.5	1,358
	31.0	−13.3	−2.8	23.1	0.2	−4.1	2.1
	242	458	2,364	269	206	322	1,948
	0.0	0.0	1,874	0.0	0.0	0.0	1,346
	242	458	2,364	269	206	322	1,948
	−0.1	0.2	−0.0	0.0	0.0	0.0	0.0
	0.1	0.1	0.0	0.0	0.0	0.0	0.0
Insurance — result & transfers
	592	674	4,522	617	357	558	3,712
	27.8	35.5	38.8	26.7	16.2	−7.7	3.6
	0.2	0.2	—	—	—	—	0.3
	0.0	0.0	1,874	0.0	0.0	0.0	1,346
Insurance — fund NPAs
	−0.0	0.0	−0.0	0.0	−0.0	0.0	−0.0
	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−0.0	0.0	−0.0	0.0	−0.0	0.0	0.0
	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	−0.0	0.0	−0.0	0.0	−0.0	0.0	0.0
	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Insurance — IRDAI ratios (as filed, not percentages)
	1.97×	1.96×	1.90×	1.91×	1.94×	1.96×	1.96×
	₹1.97	₹1.96	₹0.02	₹0.02	₹0.02	₹0.02	₹0.02
	₹0.82	₹0.88	₹0.01	₹0.01	₹0.01	₹0.01	₹0.01
	₹0.11	₹0.12	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
	₹0.86	₹0.84	₹0.01	₹0.01	₹0.01	₹0.01	₹0.01
	₹0.78	₹0.77	₹0.01	₹0.01	₹0.01	₹0.01	₹0.01
	₹0.71	₹0.71	₹0.01	₹0.01	₹0.01	₹0.01	₹0.01
	₹0.69	₹0.68	₹0.01	₹0.01	₹0.01	₹0.01	₹0.01
	₹0.58	₹0.59	₹0.01	₹0.01	₹0.01	₹0.01	₹0.01
Regulatory disclosures — filed alongside, not part of the P&L
	₹5.00	₹7.00	₹3.00	₹0.00	₹5.00	₹4.00	₹0.00
	₹5.00	₹7.00	₹3.00	₹0.00	₹5.00	₹4.00	₹0.00
	6,620	—	7,059	—	5,471	—	8,177

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SBILIFE₹1,652.00

SBI Life Insurance Company Ltd.

· Banking & Finance

Annual Quarterly₹ CrorePeersHDFCLIFE ICICIPRULI LICI SHRIRAMFIN JIOFIN BANKBARODA CANBK PNBMcap ₹1.66L Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Total Income	24,169.4	38,695.9	22,809.2	45,803.0	5,657.7	46,090.7	24,291.7
Expenses
Total Expenses	22,606.2	38,227.7	22,609.1	45,375.7	3,463.9	45,550.8	23,939.0
EBITDA	840.6	610.9	513.2	597.5	815.8	745.9	553.7
EBIT	840.6	610.9	513.2	597.5	815.8	745.9	553.7
Profit
Pretax Income	840.6	610.9	513.2	597.5	815.8	745.9	553.7
+ Current Tax	60.0	45.2	18.6	44.4	51.2	47.3	36.1
Net Income	813.5	594.4	494.6	576.7	804.6	724.9	549.2
Per Share
Basic EPS	8.11	5.93	4.93	5.75	8.02	7.22	5.47
Revenue Detail — as filed
+ Investment Income	251.1	292.9	322.3	356.3	326.0	281.6	355.8
+ Income from Investments (net)	-1,040.8	21,525.1	-2,055.3	15,531.0	-23,938.7	25,977.0	-2,613.8
Expense Detail — as filed
+ Advertisement & Publicity	76.0	43.8	42.1	56.6	95.7	54.3	35.3
+ Employee Remuneration & Welfare	681.9	709.2	827.9	1,007.8	706.9	798.6	891.6
+ Commission	997.8	666.0	1,240.3	1,610.2	859.1	929.6	1,370.0
+ Commission (net)	776.8	786.1	1,240.3	1,610.2	859.1	929.6	1,370.0
+ Provision — Diminution in Investments	6.5	-12.4	42.1	-0.8	-21.1	-0.3	164.4
+ Provision — Doubtful Debts & Write-offs	0.1	0.3	0.2	0.2	0.3	0.1	0.2
Profit Build-up — Alternate / Pre-Ind-AS Tags
Profit / (Loss) before Tax	840.6	610.9	513.2	597.5	815.8	745.9	553.7
+ Current Taxes	27.1	16.6	18.6	20.8	11.1	20.9	4.5
+ Provision for Tax	60.0	45.2	18.6	44.4	51.2	47.3	36.1
+ Provisions for Taxes	27.1	16.6	18.6	20.8	11.1	20.9	4.5
PAT before Extraordinary Items	813.5	594.4	494.6	576.7	804.6	724.9	549.2
PAT after Extraordinary Items	813.5	594.4	494.6	576.7	804.6	724.9	549.2
Profit Carried to Balance Sheet	15,630.6	16,224.9	16,719.5	17,296.2	17,830.1	18,555.0	19,104.2
Per Share — as-filed variants
Basic & Diluted EPS before Extraordinary (not annualised)	8.12	5.93	4.93	5.75	8.02	7.23	5.47
Basic & Diluted EPS after Extraordinary (not annualised)	8.11	5.93	4.93	5.75	8.02	7.22	5.47
Appropriations & Transfers
Reserves & Surplus excl. Revaluation Reserve	15,790.7	16,405.0	16,921.2	17,523.3	18,083.1	18,822.0	19,390.3
+ Interim Dividend	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Insurance — Revenue Account (Policyholders')
+ Gross Premium Income	24,001.5	17,813.9	25,083.9	30,449.5	27,938.9	21,289.7	27,115.1
+ Net Premium Income	23,860.7	17,178.5	24,848.3	30,245.3	27,683.8	20,078.2	26,877.7
+ First-year Premium	4,858.7	3,539.5	5,289.5	7,919.3	5,092.7	4,954.9	5,755.9
+ Renewal Premium	14,680.3	10,546.3	14,002.8	17,471.7	16,714.0	12,381.8	15,763.6
+ Single Premium	4,462.5	3,728.1	5,791.6	5,058.4	6,132.2	3,952.9	5,595.6
+ Commission — First-year Premium	567.1	393.5	795.3	1,085.8	416.2	612.4	874.5
+ Commission — Renewal Premium	370.8	223.9	354.2	433.8	440.3	251.5	411.3
+ Commission — Single Premium	59.9	48.7	90.8	90.6	2.6	65.7	84.2
+ Expenses of Management	2,015.1	1,915.2	2,759.2	3,519.4	2,527.4	2,565.0	3,087.5
+ Operating Expenses — Insurance Business	1,238.3	1,129.1	1,518.9	1,909.2	1,668.3	1,635.5	1,717.5
+ Expenses — Non-insurance	10.4	7.5	14.6	4.9	2.7	6.9	13.0
+ Benefits Paid (net)	12,528.3	10,118.4	13,482.1	14,468.4	16,254.6	13,126.7	15,514.5
+ Change in Actuarial Liability	7,706.0	25,899.9	6,039.2	27,347.4	-15,348.4	29,811.6	5,135.7
+ Bonus Allocated to Policyholders	1,967.2	0.0	0.0	0.0	2,060.5	0.0	0.0
+ Interim Bonus Paid	18.2	6.4	8.7	6.3	8.4	6.8	3.1
+ Terminal Bonus Paid	163.7	83.5	147.9	183.2	258.9	127.6	236.2
+ GST on Linked Charges	290.2	261.1	267.7	-3.4	-0.1	0.4	0.5
Surplus in the Revenue Account	1,563.2	468.2	200.2	427.3	2,193.8	539.9	352.7
Net Surplus / (Deficit)	1,563.2	468.2	200.2	427.3	2,193.8	539.9	352.7
+ Funds for Future Appropriation	-384.4	146.6	-5.6	158.1	-169.8	82.1	111.0
+ Policyholders' Liabilities to Shareholders' Fund	0.3	0.3	0.3	0.3	0.2	25.1	24.8
Insurance — Shareholders' Account
+ Income under Shareholders' Account	251.3	292.9	322.3	356.3	326.0	281.7	356.0
+ Shareholders' Account Income	2,199.0	614.4	528.1	625.5	2,689.6	739.5	597.7
+ Shareholders' Account Expenses	1,358.4	3.5	14.9	28.0	1,873.8	-6.3	44.0
+ Shareholders' Provision — Diminution in Investments	2.1	-4.1	0.2	23.1	-2.8	-13.3	31.0
+ Transfer from Policyholders' Account	1,947.7	321.5	205.7	269.2	2,363.6	457.8	241.7
+ Transfer of Funds to Policyholders' Account	1,345.9	0.0	0.0	0.0	1,873.9	0.0	0.0
+ Transferred to Shareholders' Account	1,947.7	321.5	205.7	269.2	2,363.6	457.8	241.7
Shareholders' Fund — with Unrealised Gains	0.0	0.0	0.0	0.0	-0.0	0.2	-0.1
Shareholders' Fund — without Unrealised Gains	0.0	0.0	0.0	0.0	0.0	0.1	0.1
Insurance — Result & Transfers
Surplus / (Deficit)	3,712.3	558.0	356.7	616.8	4,521.7	674.2	592.0
+ Other Income — Policyholders' Account	3.6	-7.7	16.2	26.7	38.8	35.5	27.8
+ Other Income — Shareholders' Account	0.3	—	—	—	—	0.2	0.2
+ Transfer of Funds from Shareholders' Account	1,345.9	0.0	0.0	0.0	1,873.9	0.0	0.0
Insurance — Fund NPAs
+ Linked Non-participating — with Unrealised Gains	-0.0	0.0	-0.0	0.0	-0.0	0.0	-0.0
+ Linked Non-participating — without Unrealised Gains	0.0	0.0	0.0	0.0	0.0	0.0	0.0
+ Non-linked Participating — with Unrealised Gains	0.0	0.0	-0.0	0.0	-0.0	0.0	-0.0
+ Non-linked Participating — without Unrealised Gains	0.0	0.0	0.0	0.0	0.0	0.0	0.0
+ Non-linked Non-participating — with Unrealised Gains	0.0	0.0	-0.0	0.0	-0.0	0.0	-0.0
+ Non-linked Non-participating — without Unrealised Gains	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Insurance — IRDAI Ratios (as filed, not percentages)
Solvency Ratio (x, one scale)	1.96	1.96	1.94	1.91	1.90	1.96	1.97
Solvency Ratio (as filed)	0.02	0.02	0.02	0.02	0.02	1.96	1.97
Conservation Ratio	0.01	0.01	0.01	0.01	0.01	0.88	0.82
Expenses of Management Ratio	0.00	0.00	0.00	0.00	0.00	0.12	0.11
Persistency — 13th Month	0.01	0.01	0.01	0.01	0.01	0.84	0.86
Persistency — 25th Month	0.01	0.01	0.01	0.01	0.01	0.77	0.78
Persistency — 37th Month	0.01	0.01	0.01	0.01	0.01	0.71	0.71
Persistency — 49th Month	0.01	0.01	0.01	0.01	0.01	0.68	0.69
Persistency — 61st Month	0.01	0.01	0.01	0.01	0.01	0.59	0.58
Regulatory Disclosures — filed alongside, not part of the P&L
Investor Complaints — Received	0.00	4.00	5.00	0.00	3.00	7.00	5.00
Investor Complaints — Disposed	0.00	4.00	5.00	0.00	3.00	7.00	5.00
Related-party Transactions — During the Period	8,176.8	—	5,470.8	—	7,058.9	—	6,620.2
Other Filed Concepts — mapped but not yet placed in the schedule
Other Operating Expenses	480.5	376.2	649.0	844.8	865.7	782.5	790.6

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

SBI Life Q2 FY27 results (July–September 2026)

Filed with NSE on Tuesday, 27 October 2026 at 6:55 pm IST

SBI Life Insurance (NSE: SBILIFE) reported its Q2 FY27 results (July–September 2026) on Tuesday, 27 October 2026 at 6:55 pm IST. Consolidated net profit was ₹549 crore, up 11.0% from ₹495 crore in Q2 FY26 and down 24.2% from ₹725 crore in Q1 FY27.

Q2 FY26 results (a year earlier): 24 October 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹549 Cr+11.0% vs Q2 FY26−24.2% vs Q1 FY27
Earnings per share (basic): ₹5.47+11.0% vs Q2 FY26−24.2% vs Q1 FY27

Questions

What was SBI Life's net profit in Q2 FY27?

Consolidated net profit was ₹549 crore, up 11.0% from ₹495 crore in Q2 FY26 and down 24.2% from ₹725 crore in Q1 FY27.

How were SBI Life's Q2 FY27 results?

Against Q2 FY26, net profit was up 11.0% at ₹549 crore. Against Q1 FY27, net profit was down 24.2%.

What was SBI Life's net profit in FY26?

Consolidated net profit was ₹2,470 crore in FY26 (April 2025–March 2026), up 2.4% from ₹2,413 crore in FY25. It was ₹1,721 crore in FY23.

What was SBI Life's EPS in Q2 FY27?

Basic earnings per share were ₹5.47, against ₹4.93 in Q2 FY26.

What was SBI Life's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹1,274 crore, up 17.0% from ₹1,089 crore in the same months a year earlier.

How has SBI Life's profit changed over the last four quarters?

Net profit by quarter: ₹577 crore in Q3 FY26, ₹805 crore in Q4 FY26, ₹725 crore in Q1 FY27 and ₹549 crore in Q2 FY27. That is ₹2,656 crore over the four quarters.

When did SBI Life announce its Q2 FY27 results?

On Tuesday, 27 October 2026 at 6:55 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 24 October 2025.

When will SBI Life announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these SBI Life figures come from?

From SBI Life Insurance's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 27 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.